RVTY Revvity, Inc.
RVTY Revvity, Inc.
Healthcare · Diagnostics & Research
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $97.16 · VWAP $109.73 · +39.1% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster VP + 1 other sold $248.8K, Sep 23–Oct 2
Coverage
1 watchlist
RVTY Price Structure
Loading timeframes…
Peers
Every watchlist RVTY belongs to, members best 30-day change first — RVTY highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
Reported the quarter ending 2026-07-05: revenue $730M, diluted EPS $0.47, net income $52M (SEC filing). Across the print the stock moved -0.2% (close before → first close after).
full note →Against street estimates
How RVTY's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about RVTY from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 17
- RVTY News Today | Why did Revvity stock go up today? $RVTY
- Revvity posts solid Q2 2026 earnings growth - TipRanks.com
- Revvity to Hold Earnings Call on November 3, 2026
- RVTY Stock Price Quote | Morningstar
- Revvity Announces Financial Results for the Second Quarter of 2026
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
RVTY research tape
42 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.